Formula milk companies push allergy products despite flawed evidence

Europe has toughened its approach to formula milk products that claim to reduce allergy risks. But consumers elsewhere continue to be coaxed into buying products that make health claims without high quality evidence. Melanie Newman reports

Detalles Bibliográficos
Autor principal: Newman, Melanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2022
Materias:
Feature
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879268/
https://www.ncbi.nlm.nih.gov/pubmed/35296503
http://dx.doi.org/10.1136/bmj.o630
_version_ 1784878655271337984
author Newman, Melanie
author_facet Newman, Melanie
author_sort Newman, Melanie
collection PubMed
description Europe has toughened its approach to formula milk products that claim to reduce allergy risks. But consumers elsewhere continue to be coaxed into buying products that make health claims without high quality evidence. Melanie Newman reports
format Online
Article
Text
id pubmed-9879268
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group Ltd.
record_format MEDLINE/PubMed
spelling pubmed-98792682023-01-27 Formula milk companies push allergy products despite flawed evidence Newman, Melanie BMJ Feature Europe has toughened its approach to formula milk products that claim to reduce allergy risks. But consumers elsewhere continue to be coaxed into buying products that make health claims without high quality evidence. Melanie Newman reports BMJ Publishing Group Ltd. 2022-03-16 /pmc/articles/PMC9879268/ /pubmed/35296503 http://dx.doi.org/10.1136/bmj.o630 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Feature
Newman, Melanie
Formula milk companies push allergy products despite flawed evidence
title Formula milk companies push allergy products despite flawed evidence
title_full Formula milk companies push allergy products despite flawed evidence
title_fullStr Formula milk companies push allergy products despite flawed evidence
title_full_unstemmed Formula milk companies push allergy products despite flawed evidence
title_short Formula milk companies push allergy products despite flawed evidence
title_sort formula milk companies push allergy products despite flawed evidence
topic Feature
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879268/
https://www.ncbi.nlm.nih.gov/pubmed/35296503
http://dx.doi.org/10.1136/bmj.o630
work_keys_str_mv AT newmanmelanie formulamilkcompaniespushallergyproductsdespiteflawedevidence

Ejemplares similares